APPLICATION
ANDA075138
TYPE
ANDA
ORIGINAL APPROVAL
1999-04-20
LATEST ACTION
2021-03-02
ROUTE
ORAL
DOSAGE FORM
CAPSULE, EXTENDED RELEASE
MARKETING STATUS
Prescription
Products
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 180MG · CAPSULE, EXTENDED RELEASE · ORAL
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 240MG · CAPSULE, EXTENDED RELEASE · ORAL
VERAPAMIL HYDROCHLORIDEPrescription
VERAPAMIL HYDROCHLORIDE 120MG · CAPSULE, EXTENDED RELEASE · ORAL
Approval history
2021-03-02Labeling · Supplement 19 · standardAP
2019-09-27Labeling · Supplement 17 · standardAP
2015-10-27Labeling · Supplement 15 · standardAP
2015-10-27Labeling · Supplement 13 · standardAP
2010-08-12Labeling · Supplement 12AP
2009-12-03Labeling · Supplement 11AP
2001-03-30Labeling · Supplement 3AP
2000-02-09Labeling · Supplement 2AP
1999-11-04Labeling · Supplement 1AP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.